Newsroom

IRVINE, Californie et AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., leader dans le domaine de l’oncologie de précision pour le cancer du sein, a annoncé aujourd’hui la décision officielle de l’Office fédéral de la santé publique (OFSP) d’accorder une prise en charge définitive et obligatoire par l’assurance maladie (Obligatorische Krankenpflegeversicherung, ou OKP) des tests d’expression multigénique, y compris MammaPrint®, pour les patientes éligibles atteintes d’un cancer du sein à un stade pré...

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2026-1 PLC   GBP 26,410,000.00   MATURING: 20-Jan-2068   ISIN: XS3346959052     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 23-Apr-2026 TO 20-Jul-2026 HAS BEEN FIXED AT 4.80 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Jul-2026 WILL AMOUNT TO: GBP 321,479.75 PER GBP 27,800,000.00 DENOMINATION  ...

IRVINE, Kalifornien & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., ein führendes Unternehmen im Bereich der Präzisionsonkologie bei Brustkrebs, gab heute die offizielle Entscheidung des Schweizer Bundesamtes für Gesundheit (BAG) bekannt, eine endgültige, obligatorische Erstattung durch die Krankenpflegeversicherung (OKP) für Multigen-Expressions-Tests, einschließlich MammaPrint®, für berechtigte Patientinnen mit Brustkrebs im Frühstadium zu gewähren. Die Tests sollen als Entscheidungshilfe bei d...

ATLANTA--(BUSINESS WIRE)--HB Wealth (HB), one of the nation's largest independent, fee-only registered investment advisers, has launched a dedicated Institutional Advisory and Outsourced Chief Investment Officer (OCIO) practice. The business segment formalizes the firm's longstanding institutional relationships across nonprofit, foundation, endowment, and corporate clients, into a purpose-built advisory offering. As part of the launch, the firm has hired Mike Hill and Armond Reese, CFA, CAIA, A...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Ultralytics, the company behind the YOLO family of object detection models, today announced collaboration with Intel to bring production-ready YOLO (You Only Look Once) computer vision models to Intel hardware, making real-time vision AI faster, easier, and more cost-effective to deploy across industries from robotics to manufacturing, logistics, and security.Most real-world vision AI technologies run on existing, CPU-based infrastructures including industri...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 13.07.2026 GAUG LN IE000TGSG3Y5  400,002.00 USD  14,895,172.40   37.238  ...

PALO ALTO, Calif. & JOINVILLE, Brazil--(BUSINESS WIRE)--Agentic risk platform Oscilar partners with Conta Azul, a Visma company, to strengthen fraud prevention, onboarding and risk operations across Brazil....

CHARLOTTE, N.C.--(BUSINESS WIRE)--ClearGen Holdings, LLC today announced the acquisition of a 19-megawatt (MW) portfolio of operating commercial and industrial (C&I) solar assets from affiliates of Tortoise Capital Advisors. The acquisition consists of 10 operating behind-the-meter solar projects located across California, Colorado, Florida, Massachusetts, and New Jersey. ClearGen acquired 100% of the equity interests in the portfolio and will assume asset management responsibilities for th...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 13.07.2026 GNOV LN IE000OJ31JQ4 1,000,002.00 USD  36,979,883.78   36.980  ...

VANCOUVER, Wash.--(BUSINESS WIRE)--ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, has reported that BDO Canada, a leading advisory firm serving clients from startups to enterprises, has cut the time to update its market intelligence dashboards from eight hours to one, an 87% reduction, according to the company. For an advisory firm, market intelligence is the edge. The difference between winning and losing a high-value relationship often comes down to knowing what a client needs before...